Ironwood Pharmaceuticals IRWD Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Ironwood Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ironwood Pharmaceuticals's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ironwood Pharmaceuticals's operating cash flow?
- Ironwood Pharmaceuticals (IRWD) reported operating cash flow of $5.12M in Q1 2026.
- How has Ironwood Pharmaceuticals's operating cash flow changed year-over-year?
- Ironwood Pharmaceuticals's operating cash flow decreased by 74.3% year-over-year, from $19.95M to $5.12M.
- What is the long-term trend for Ironwood Pharmaceuticals's operating cash flow?
- Over 3 years (2021 to 2024), Ironwood Pharmaceuticals's operating cash flow has grown at a -26.6% compound annual growth rate (CAGR), from $261.9M to $103.55M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.